Molina Vázquez M E, Somoza Arguibay I, Palacios M G, Gómez Veiras J R, González M, Tellado M, Pais E, Dargallo T, Vela D
Servicio de Cirugía Pediátrica, Complejo Hospitalario Universitario La Coruña.
Cir Pediatr. 2010 Oct;23(4):236-40.
Dysfunctional voiding syndrome in children is characterized by a pattern of dysfunctional bladder emptying due to an active contraction of the external sphincter during micturition. Diagnosis is based on electromyographic and flowmetry results. The treatment is focused on relaxing the external sphincter during micturition where biofeedback is the treatment of choice. By the moment there are still centres without this possibility, alpha blockers are an alternative.
To determine the efficacy of alpha blockers as an alternative to biofeedback as a therapeutic possibility.
We included a total of 17 children with dysfunctional voiding syndrome and carried out a retrospective study. We registered age, symptoms at diagnosis, presence of associated urologic problems, flowmetry results pre and post-treatment, type of treatment used and its effectiveness comparing patients treated with alpha blockers and those who are starting to deal with biofeedback.
There were 12 girls and 5 boys. The mean age at diagnosis was 4.9 years old, 88% of these children related enuresis, diurnal urinary incontinence and urgency, 57% of them had also urinary infections, 63% constipation, 36% had psychosocial problems. Ten patients were treated with alpha-antagonists: 6 with Tamsulosin and 4 with Doxazosin. They followed this treatment an average of 5.8 months, range between 2 and 12 months. Five patients were treated with biofeedback. All cases had an abnormal pelvic electromyography. Patients treated with alpha-blockers achieved a 70% of electromyographic improvement with a 70% of recurrence. In children treated with biofeedback we got improvement in 80% with no recurrence. After alpha blocker therapy, maximum flow rates and average flow values were better but not statistically significant, this difference was significant with biofeedback. A patient treated with Tamsulosin left treatment due to hypotension, 2 patients left Doxazosin because of dizziness.
Alpha-blockers are effective in the treatment of dysfunctional voiding syndrome with a high percentage of recurrence. They can be an alternative to biofeedback but this one is the effective and definitive treatment.
儿童功能性排尿障碍综合征的特征是排尿时由于外括约肌主动收缩导致膀胱排空功能失调。诊断基于肌电图和尿流率检查结果。治疗重点是在排尿时放松外括约肌,生物反馈是首选治疗方法。目前仍有一些中心无法进行生物反馈治疗,α受体阻滞剂是一种替代选择。
确定α受体阻滞剂作为生物反馈治疗替代方法的疗效。
我们纳入了总共17例功能性排尿障碍综合征患儿并进行了一项回顾性研究。我们记录了年龄、诊断时的症状、相关泌尿系统问题的存在情况、治疗前后的尿流率检查结果、所用治疗类型及其有效性,比较了接受α受体阻滞剂治疗的患者和开始接受生物反馈治疗的患者。
有12名女孩和5名男孩。诊断时的平均年龄为4.9岁,这些儿童中88%有遗尿、日间尿失禁和尿急症状,57%还患有泌尿系统感染,63%有便秘,36%有心理社会问题。10例患者接受了α受体拮抗剂治疗:6例使用坦索罗辛,4例使用多沙唑嗪。他们平均接受这种治疗5.8个月,范围在2至12个月之间。5例患者接受了生物反馈治疗。所有病例的盆腔肌电图均异常。接受α受体阻滞剂治疗的患者肌电图改善率为70%,复发率为70%。接受生物反馈治疗的儿童改善率为80%,无复发。α受体阻滞剂治疗后,最大尿流率和平均尿流值有所改善,但无统计学意义,生物反馈治疗的差异具有统计学意义。1例接受坦索罗辛治疗的患者因低血压退出治疗,2例接受多沙唑嗪治疗的患者因头晕退出。
α受体阻滞剂对功能性排尿障碍综合征有效,但复发率较高。它们可以作为生物反馈治疗的替代方法,但生物反馈治疗是有效且 definitive(此处原文有误,可能是“definitive”,意为“决定性的”)的治疗方法。